Selected article for: "asymptomatic cohort and symptomatic cohort"

Author: Le Bert, Nina; Clapham, Hannah E.; Tan, Anthony T.; Chia, Wan Ni; Tham, Christine Y.L.; Lim, Jane M.; Kunasegaran, Kamini; Tan, Linda Wei Lin; Dutertre, Charles-Antoine; Shankar, Nivedita; Lim, Joey M.E.; Sun, Louisa Jin; Zahari, Marina; Tun, Zaw Myo; Kumar, Vishakha; Lim, Beng Lee; Lim, Siew Hoon; Chia, Adeline; Tan, Yee-Joo; Tambyah, Paul Anantharajah; Kalimuddin, Shirin; Lye, David; Low, Jenny G.H.; Wang, Lin-Fa; Wan, Wei Yee; Hsu, Li Yang; Bertoletti, Antonio; Tam, Clarence C.
Title: Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection
  • Cord-id: vtidvrqr
  • Document date: 2021_3_1
  • ID: vtidvrqr
    Snippet: The efficacy of virus-specific T cells in clearing pathogens involves a fine balance between antiviral and inflammatory features. SARS-CoV-2–specific T cells in individuals who clear SARS-CoV-2 without symptoms could reveal nonpathological yet protective characteristics. We longitudinally studied SARS-CoV-2–specific T cells in a cohort of asymptomatic (n = 85) and symptomatic (n = 75) COVID-19 patients after seroconversion. We quantified T cells reactive to structural proteins (M, NP, and Sp
    Document: The efficacy of virus-specific T cells in clearing pathogens involves a fine balance between antiviral and inflammatory features. SARS-CoV-2–specific T cells in individuals who clear SARS-CoV-2 without symptoms could reveal nonpathological yet protective characteristics. We longitudinally studied SARS-CoV-2–specific T cells in a cohort of asymptomatic (n = 85) and symptomatic (n = 75) COVID-19 patients after seroconversion. We quantified T cells reactive to structural proteins (M, NP, and Spike) using ELISpot and cytokine secretion in whole blood. Frequencies of SARS-CoV-2–specific T cells were similar between asymptomatic and symptomatic individuals, but the former showed an increased IFN-γ and IL-2 production. This was associated with a proportional secretion of IL-10 and proinflammatory cytokines (IL-6, TNF-α, and IL-1β) only in asymptomatic infection, while a disproportionate secretion of inflammatory cytokines was triggered by SARS-CoV-2–specific T cell activation in symptomatic individuals. Thus, asymptomatic SARS-CoV-2–infected individuals are not characterized by weak antiviral immunity; on the contrary, they mount a highly functional virus-specific cellular immune response.

    Search related documents:
    Co phrase search for related documents
    • accumulate evidence and adaptive immune response: 1
    • active spread and acute infection: 1, 2
    • active spread and additional parameter: 1
    • acute infection and adaptive antiviral immunity: 1
    • acute infection and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute infection and adaptive immunity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute phase and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8
    • acute phase and adaptive immunity: 1, 2, 3, 4, 5, 6, 7